UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000019294
Receipt number R000022199
Scientific Title The clinical utility of next generation optical coherence tomography for accessory visual structurescoherence tomography
Date of disclosure of the study information 2015/12/01
Last modified on 2018/04/11 09:31:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The clinical utility of next generation optical coherence tomography for accessory visual structurescoherence tomography

Acronym

The clinical utility of OCT for accessory visual structures

Scientific Title

The clinical utility of next generation optical coherence tomography for accessory visual structurescoherence tomography

Scientific Title:Acronym

The clinical utility of OCT for accessory visual structures

Region

Japan


Condition

Condition

accessory visual structures

Classification by specialty

Ophthalmology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Evaluating clinical utility of next generation optical coherence tomography for accessory visual structures

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Comparison between normal and disease states in lacrimal apparatus using OCT image

Key secondary outcomes

Comparison between benign and malignant eyelid tumor using OCT image


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

Evaluating accessory visual structures in disease states using next generation optical coherence tomography
Intervention frequency is 3 times; initial visit, postoperative monnths 2,6.

Interventions/Control_2

Evaluating accessory visual structures in normal states using next generation optical coherence tomography
Intervention frequency is one time.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

1.patients who were diagnosed as lacrimal disease or eyelid tumor in Kyoto university
2.patients who are normal states in accessory visual structures

Key exclusion criteria

1.patients who had allergy caused by rebamipido eye-drop
2.patients who didn't agree with this study
3.patients who were judged to be unsuitable to this study by us

Target sample size

130


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Nagahisa Yoshihisa

Organization

Kyoto University Graduate School of Medicine

Division name

Department of Ophthalmology and Visual Sciences

Zip code


Address

54 Shogoin-Kawaracho, Sakyou, Kyoto 606-8507

TEL

075-751-3250

Email

nagaeye@kuhp.kyoto-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Masahiro Fujimoto

Organization

Kyoto University Graduate School of Medicine

Division name

Department of Ophthalmology and Visual Sciences

Zip code


Address

54 Shogoin-Kawaracho, Sakyou, Kyoto 606-8507

TEL

075-751-3250

Homepage URL


Email

m2fjmt@kuhp.kyoto-u.ac.jp


Sponsor or person

Institute

Kyoto University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

japan society for promotion of science

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

京都大学医学部附属病院(京都府)


Other administrative information

Date of disclosure of the study information

2015 Year 12 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2015 Year 10 Month 01 Day

Date of IRB


Anticipated trial start date

2015 Year 12 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 10 Month 09 Day

Last modified on

2018 Year 04 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022199


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name